Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-27

FDA Approved: TRIMIPRAMINE MALEATE — Supplemental Application (Elite Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application for trimipramine maleate from Elite Laboratories, Inc., effectively approving a change to an existing generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trimipramine Maleate (Trimipramine maleate)

Snippet

SUPPL AP for TRIMIPRAMINE MALEATE (TRIMIPRAMINE MALEATE)